Latest Regulatory Progress News

Rox Resources has ramped up underground mining and advanced processing plant development at its Youanmi Gold Project, signalling a strong push towards production in 2026. Key infrastructure expansions and strategic hires underpin the company’s growth ambitions.

Ore Resources Ltd has identified nine promising gold targets at its Randalls North tenements through detailed geophysical and geochemical analysis, setting the stage for an active 2026 exploration campaign.

St George Mining has announced a significant high-grade niobium discovery 400 metres outside its existing Araxá Mineral Resource Estimate, potentially expanding one of the world’s premier niobium projects.

Island Pharmaceuticals has been granted a key US patent for Galidesivir, extending intellectual property protection through 2031 for treating filoviridae viruses including Marburg and Ebola. This milestone aligns with the company’s clinical development strategy and recent FDA regulatory progress.

Titanium Sands Limited has lodged an Industrial Mining License application for its Mannar Heavy Minerals Project in Sri Lanka, marking a pivotal step towards production. The project boasts a substantial mineral resource and is progressing through environmental and feasibility milestones despite recent cyclone delays.

Global Laser Enrichment, licensee of Silex’s laser uranium enrichment technology, has won a $28 million U.S. Department of Energy award to push next-gen nuclear fuel innovation, despite missing out on a larger $900 million contract.

Nexsen Limited has initiated FDA engagement for its rapid Group B Streptococcus diagnostic sensor, aiming for expedited US market entry, while bolstering its leadership team and scientific credentials.

New Frontier Minerals has moved its Mining Lease Application for the Big One Copper Deposit into the technical assessment phase, marking a key step toward near-term development amid a strong copper market.

Kingsland Minerals has initiated a Pre-feasibility Study for its Leliyn Graphite Project and commenced key metallurgical testing with offtake partner Quinbrook, aiming to produce battery-grade spherical graphite.

Silver Mines Limited advances the Bowdens Silver Project by updating ecological surveys under new biodiversity laws, aiming for a legally robust development application redetermination by mid-2026.

Neuren Pharmaceuticals has secured Health Canada approval to expand its pivotal Phase 3 trial of NNZ-2591 for Phelan-McDermid syndrome into Canadian sites, complementing ongoing US enrolment.

Clarity Pharmaceuticals has secured positive FDA guidance to initiate a pivotal Phase III trial of its Cu-64 SARTATE diagnostic agent for neuroendocrine tumours, aiming to improve detection and patient outcomes.